RJR-2429
RJR-2429 is a drug that acts as an agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. RJR-2429 is stronger than nicotine but weaker than epibatidine in most assays, and with high affinity for both α3β4 and α4β2 subtypes, as well as the less studied α1βγδ subtype.
primaryTopic
RJR-2429
RJR-2429 is a drug that acts as an agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. RJR-2429 is stronger than nicotine but weaker than epibatidine in most assays, and with high affinity for both α3β4 and α4β2 subtypes, as well as the less studied α1βγδ subtype.
has abstract
RJR-2429 is a drug that acts a ...... he less studied α1βγδ subtype.
@en
CAS number
91556-75-1
IUPAC name
2-(3-Pyridinyl)-1-azabicyclo[2.2.2]octane
@en
PubChem
thumbnail
Wikipage page ID
36,515,522
Wikipage revision ID
702,437,272
molecular weight
smiles
hypernym
comment
RJR-2429 is a drug that acts a ...... he less studied α1βγδ subtype.
@en
label
RJR-2429
@en
